Search results for: pediatric

The Amazing Volunteers Who Make Up the American College of Rheumatology Board of Directors

James R. O’Dell, MD | May 9, 2012

Our members come together for the good of the organization and our leadership, regardless of background or career path.

What’s In A Note?: The Use of Electronic Health Records

Simon M. Helfgott, MD | May 9, 2012

The dictum “to write as long as possible” has become the norm for some physicians. Quality, not quantity, should be our goal.

Growing Up Confident with Juvenile Idiopathic Arthritis

Staff | May 9, 2012

While juvenile arthritis can cause joint damage and limit function, rheumatologists strongly encourage children with JIA to live normal lives.

Patient Fact Sheet: Juvenile Idiopathic Arthritis

Staff | May 9, 2012

Several types of arthritis fall under the JIA heading. This inflammation begins before patients reach the age of 16 years, and may involve one or many joints and cause other symptoms such as fevers, rash, and eye inflammation.

Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

Gretchen Henkel | May 8, 2012

Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

The American College of Rheumatology (ACR) can Help Combat Insurance Frustrations

James R. O’Dell, MD | April 6, 2012

When it comes to dealing with insurance companies, the rules seem to change frequently and always in an arbitrary and capricious way. The ACR is trying its best to protect rheumatologists, but we need your help!

Association of Rheumatology Health Professionals (ARHP) Recognizes 2011 Graduate Student Award Recipients

Staff | April 6, 2012

The ARHP Graduate Student Award, established in 2006, is given annually to outstanding students in recognition of their research and clinical practice projects in the field of rheumatology. The ARHP is honored to recognize its 2011 Graduate Student Award recipients: Jennifer Mei Ping Woo and Andrew Galica.

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden | April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

Pinpoint Cognitive Dysfunction in Patients with Lupus

Vanessa Caceres | April 6, 2012

More than 80% of SLE patients experience some type of neurologic manifestation during their disease course. The challenge for rheumatologists and other clinicians lies in appropriately diagnosing any cognitive dysfunctions that accompany lupus and better understanding the causes and risk factors of those dysfunctions. “Cognitive Function in SLE” was the focus of a talk at the 2011 ACR/ARHP Annual Scientific Meeting in November.

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD | March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.